Education
About Us
Working with TipRanks
Follow Us
Noxopharm Ltd. (AU:NOX)
:NOX
NOX Stock Chart & Stats
Day’s Range― - ―
52-Week RangeAU$0.04 - AU$0.15
Previous CloseN/A
Volume154.85K
Average Volume (3M)267.48K
Market Cap
AU$20.75M
Enterprise ValueAU$14.74M
Total Cash (Recent Filing)AU$4.18M
Total Debt (Recent Filing)AU$0.00
Price to Earnings (P/E)―
Beta-0.85
Next Earnings
Aug 21, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding292,237,950
10 Day Avg. Volume408,495
30 Day Avg. Volume267,479
Financial Highlights & Ratios
PEG Ratio-0.17
Price to Book (P/B)3.25
Price to Sales (P/S)0.00
P/FCF Ratio-3.44
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Noxopharm Ltd. News
PremiumCompany Announcements
Noxopharm Initiates First SOF-SKN™ Dose in HERACLES Trial
PremiumCompany Announcements
Noxopharm Advances HERACLES Clinical Trial for Autoimmune Drug
PremiumCompany Announcements
Noxopharm’s Sofra Platform Shows Promising Results in BioRay Collaboration
PremiumCompany Announcements
Noxopharm Secures Ethics Approval for Pioneering HERACLES Clinical Trial
PremiumCompany Announcements
Noxopharm Reduces Stake in Nyrada Inc.PremiumCompany Announcements
Noxopharm Sells Entire Stake in Nyrada Inc., Restructuring Corporate HoldingsPremiumCompany Announcements
Noxopharm Secures $2.5 Million for Clinical Trials and R&D
PremiumCompany Announcements
Noxopharm Unveils Promising SOF-SKN Data at Rheumatology ConferenceNOX FAQ
What was Noxopharm Ltd.’s price range in the past 12 months?
Noxopharm Ltd. lowest share price was AU$0.04 and its highest was AU$0.15 in the past 12 months.
What is Noxopharm Ltd.’s market cap?
Noxopharm Ltd.’s market cap is AU$20.75M.
When is Noxopharm Ltd.’s upcoming earnings report date?
Noxopharm Ltd.’s upcoming earnings report date is Aug 21, 2025 which is in 25 days.
How were Noxopharm Ltd.’s earnings last quarter?
Currently, no data Available
Is Noxopharm Ltd. overvalued?
According to Wall Street analysts Noxopharm Ltd.’s price is currently Overvalued.
Does Noxopharm Ltd. pay dividends?
Noxopharm Ltd. does not currently pay dividends.
What is Noxopharm Ltd.’s EPS estimate?
Noxopharm Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Noxopharm Ltd. have?
Noxopharm Ltd. has 292,237,950 shares outstanding.
What happened to Noxopharm Ltd.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Noxopharm Ltd.?
Currently, no hedge funds are holding shares in AU:NOX
Noxopharm Ltd. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:NOX Sentiment 70%
Sector Average 72%
Sector Average 72%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
7.14%
12-Months-Change
Fundamentals
Return on Equity
-42.50%
Trailing 12-Months
Asset Growth
-23.62%
Trailing 12-Months
Company Description
Noxopharm Ltd.
Noxopharm Ltd. (NOX) is an Australian-based biotechnology company that focuses on the development of innovative oncology drug candidates. The company's core products are centered around its proprietary drug technology designed to enhance the effectiveness of existing cancer treatments, particularly in enhancing the body's response to radiotherapy and chemotherapy. Noxopharm operates within the pharmaceutical and biotechnology sectors, aiming to address unmet medical needs in cancer treatment through its novel drug formulations.
Technical Analysis
Opthea
―
Biotron
―
PYC Therapeutics Limited
―
Race Oncology Ltd.
―
Proteomics International Laboratories Ltd.
―